Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
newsroom.csl
2d
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Temporary marketing authorization is based on statistically significant and clinically meaningful results from the phase-III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Reaches tentative union deal
OK classroom Bible suit
Judge unseals new evidence
Republicans appeal ruling
At decade-high level
Nationwide blackout in Cuba
La Nina could arrive soon
Emergency abortion ruling
Fire prompts evacuations
Opioid suits settlement deal
To furlough 700 workers
2024 induction ceremony
Ex-MN congressman dies
School shooting report
Bladder cancer drug pulled
US deficit reaches $1.8T
NK sending troops to RU?
NC breaks turnout record
Three Americans detained
G7 ministers back Ukraine
Challenges military listing
Calif. oil refinery closure
Frozen waffles recalled
Antitrust ruling delayed
Probes near miss in Austin
Netanyahu's home targeted
Philip Zimbardo dies at 91
PG&E shuts off power
Feedback